Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Sionna Therapeutics, Inc. (SION) had Weighted-Average Shares Outstanding (Diluted) of 45.15M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-29.89M |
|
-- |
|
-- |
|
$32.47M |
|
$-32.47M |
|
$2.58M |
|
$-29.89M |
|
$-29.89M |
|
$-29.89M |
|
$-29.89M |
|
$-29.89M |
|
$-29.89M |
|
$-32.47M |
|
$-32.47M |
|
45.15M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
45.15M |
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$216.13M |
|
$1.92M |
|
$67.12M |
|
$283.25M |
|
$10.78M |
|
-- |
|
$6.69M |
|
$17.47M |
|
$265.77M |
|
$265.77M |
|
$265.77M |
|
45.16M |
|
| Cash Flow Statement Financials | |
$-44.06M |
|
$46.29M |
|
$2.64M |
|
$59.41M |
|
$64.28M |
|
$4.87M |
|
$13.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.24% |
|
-11.24% |
|
-10.55% |
|
-11.24% |
|
$5.88 |
|
$-0.98 |
|
$-0.98 |
|